OFG
ZVSA

OTA Financial Group’s ZyVersa Therapeutics ZVSA Stock Holding History

OTA Financial Group’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-83
Closed -$290K – 99
2022
Q3 		$290K Buy
+83
New +$290K 0.25% 68

Other funds holding ZVSA

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

OTA Financial Group's ZVSA Position: Q4 2022 in Review

OTA Financial Group sold out of ZyVersa Therapeutics (ZVSA) in Q4 2022, closing a stake of 83 shares — an estimated $290K sold.

OTA Financial Group first reported a position in ZVSA in Q3 2022 and held it in 1 quarter. The position peaked at $290K in Q3 2022. 2 funds tracked by Wall St. Rank hold ZVSA as of Q4 2022.

  • OTA Financial Group reported no remaining ZyVersa Therapeutics position as of Q4 2022 after selling out during the quarter.
  • OTA Financial Group sold 83 ZyVersa Therapeutics shares in Q4 2022, an estimated $290K.
  • OTA Financial Group first reported a position in ZyVersa Therapeutics in Q3 2022 and held it in 1 quarter.
  • OTA Financial Group's ZyVersa Therapeutics position peaked at $290K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held ZyVersa Therapeutics as of Q4 2022.

Based on OTA Financial Group's 13F filing for Q4 2022, filed 9 Feb 2023.